Confluence Investment Management LLC Boosts Stake in The Clorox Company $CLX

Key Points

• Confluence Investment Management LLC increased its stake in The Clorox Company by 12%, owning approximately 941,510 shares after purchasing an additional 100,764 shares in Q2.
• The Clorox Company reported $2.87 earnings per share for its last quarter, surpassing analysts' estimates, and its revenue increased by 4.5% year-over-year.
• The company declared a quarterly dividend of $1.24, raising it from the previous $1.22, representing an annual yield of 4.0%.

Confluence Investment Management LLC raised its stake in The Clorox Company (NYSE:CLX - Free Report) by 12.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 941,510 shares of the company's stock after buying an additional 100,764 shares during the period. Clorox accounts for 1.6% of Confluence Investment Management LLC's holdings, making the stock its 24th largest holding. Confluence Investment Management LLC owned approximately 0.76% of Clorox worth $113,047,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently modified their holdings of CLX. Hsbc Holdings PLC raised its stake in shares of Clorox by 118.8% during the first quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company's stock valued at $159,699,000 after acquiring an additional 589,544 shares during the last quarter. KBC Group NV raised its stake in Clorox by 688.7% during the first quarter. KBC Group NV now owns 587,679 shares of the company's stock worth $86,535,000 after buying an additional 513,171 shares during the last quarter. AQR Capital Management LLC raised its stake in Clorox by 412.1% during the first quarter. AQR Capital Management LLC now owns 598,758 shares of the company's stock worth $88,167,000 after buying an additional 481,846 shares during the last quarter. Goldman Sachs Group Inc. raised its stake in Clorox by 147.6% during the first quarter. Goldman Sachs Group Inc. now owns 707,005 shares of the company's stock worth $104,107,000 after buying an additional 421,453 shares during the last quarter. Finally, GAMMA Investing LLC raised its stake in Clorox by 11,108.0% during the first quarter. GAMMA Investing LLC now owns 349,130 shares of the company's stock worth $51,409,000 after buying an additional 346,015 shares during the last quarter. Institutional investors own 78.53% of the company's stock.

Clorox Stock Down 0.3%

CLX stock traded down $0.32 during trading on Thursday, reaching $125.08. The stock had a trading volume of 656,979 shares, compared to its average volume of 1,658,951. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The company has a market capitalization of $15.30 billion, a price-to-earnings ratio of 19.19, a P/E/G ratio of 1.00 and a beta of 0.52. The Clorox Company has a one year low of $116.53 and a one year high of $171.37. The company's 50 day moving average is $124.21 and its two-hundred day moving average is $131.81.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping the consensus estimate of $2.24 by $0.63. The company had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. Clorox's revenue for the quarter was up 4.5% on a year-over-year basis. During the same period last year, the firm earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Equities research analysts forecast that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be issued a $1.24 dividend. This represents a $4.96 annualized dividend and a yield of 4.0%. The ex-dividend date of this dividend is Wednesday, October 22nd. Clorox's dividend payout ratio (DPR) is presently 76.07%.

Insider Buying and Selling

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the firm's stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares of the company's stock, valued at $6,711,475.38. This trade represents a 21.72% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.57% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Wells Fargo & Company lowered their target price on shares of Clorox from $138.00 to $130.00 and set an "equal weight" rating for the company in a research note on Friday, September 5th. Jefferies Financial Group lowered their target price on shares of Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a research note on Thursday, June 26th. Barclays lowered their target price on shares of Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a research note on Tuesday, July 15th. UBS Group dropped their price objective on shares of Clorox from $150.00 to $134.00 and set a "neutral" rating on the stock in a report on Thursday, July 17th. Finally, JPMorgan Chase & Co. raised their target price on Clorox from $133.00 to $135.00 and gave the company a "neutral" rating in a research note on Monday, September 8th. One equities research analyst has rated the stock with a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Reduce" and a consensus target price of $142.18.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.